Strive Health Valuation, Funding & Investors

Strive Health is valued at $1.8B as of September 2025.

Last Strive Health valuation

$1.8B

Series D · Sep 2025

Last Strive Health funding round

$300M

Series D · Sep 2025

Cumulative funding Strive Health raised

$686M

across 4 funding rounds

Key investors in Strive Health

  • New Enterprise Associates
  • Echo Health Ventures
  • Town Hall Ventures
  • Redpoint
  • CapitalG
  • Ascension Ventures

Strive Health Overview

About Strive Health

Strive Health is a value-based kidney care provider partnering with payers and clinics to manage chronic kidney disease patients from early stages through dialysis. Its technology-enabled model coordinates care across primary providers and specialists, operating in multiple U.S. states with backing from investors like New Enterprise Associates.


Founded

2018

HQ

United StatesDenver, CO

Status

Privately held

Customer focus

B2B

Revenue model

Services, Subscription

Valuation

$1.8B (Sep 2025)

Strive Health Valuation

Strive Health is currently valued at $1.8B, based on its Series D in September 2025.

The $300M round was led by New Enterprise Associates, with participation from Redpoint, Town Hall Ventures, BlackRock, CapitalG, CVS Health Ventures and 1 other investor.

Strive Health valuation by funding round

Strive Health valuation by funding round
DateStageValuation
Sep 2025Series D$1.8B

Strive Health Funding History

Strive Health has raised a total of $686M across 4 funding rounds.

Strive Health's first fundraising round was a $80M Series A in April 2019. The most recent completed round was a $300M Series D in September 2025.

Strive Health funding rounds

Strive Health funding rounds
DateStageInvestorsRaisedValuationDeal Summary
Sep 2025Series DNew Enterprise Associates (lead); Redpoint; Town Hall Ventures; BlackRock; CapitalG; CVS Health Ventures; Echo Health Ventures$300M$1.8BStrive Health is a value-based kidney care platform supporting patients with chronic and end-stage kidney disease across 50 states, managing nearly $5 billion in medical spend for 145,000 patients as of late 2025. The company, founded in 2018, employs over 700 staff and delivers outcomes including 20% reduction in total cost of care, 41% reduction in hospitalizations, 11% reduction in ED visits, 42% increase in nephrology visits, 94% patient satisfaction, and 85% increase in optimal dialysis starts. It partners with investors like New Enterprise Associates, CVS Health Ventures, CapitalG, Redpoint, Town Hall Ventures, and Echo Health Ventures. In 2025, Strive Health completed a Series D capital raise of $550 million, consisting of $300 million in equity and $250 million in debt financing, led by New Enterprise Associates. Prior to this, total funding stood at $389 million as of Q2 2025. Strive Health's model focuses on high-value, low-cost care through predictive analytics, chronic disease management, and value-based care implementation. It has been recognized as a best place to work and its CEO honored as a Most Admired CEO in 2023 and Entrepreneur of the Year in 2021. Earlier metrics from Q2 2025 showed support for 110,000 patients with $3.8 billion in medical spend under management, indicating growth into late 2025.
May 2023Series CNew Enterprise Associates (lead); Redpoint; Town Hall Ventures; CapitalG; CVS Health Ventures; Echo Health Ventures; Ascension Ventures$166M-Strive Health is a national leader in value-based kidney care, providing end-to-end care for patients with chronic kidney disease (CKD) and end-stage kidney disease (ESKD). On May 31, 2023, the company raised $166 million in a Series C funding round led by New Enterprise Associates (NEA), with participation from CVS Health Ventures, CapitalG (Alphabet), Echo Health Ventures, Town Hall Ventures, Ascension Ventures, and Redpoint. At the time, Strive managed over $2.5 billion in annual medical spend, served 80,000 patients across 30 states, partnered with over 600 nephrology providers in 10 states, and employed 550 people. The funding was intended to expand into new markets, strengthen partnerships with payors, health systems, nephrologists, and medical groups, refine its clinical value-based care model, and invest in its workforce. Strive's approach integrates technology-enabled interventions with local provider networks, distinguishing it from competitors by targeting both health insurers and kidney specialists. Investors highlighted the company's proven ability to improve clinical outcomes while reducing total cost of care. By 2025, Strive raised a $550 million round ($300M Series D equity led by NEA plus $250M debt), reaching $1.8B valuation, $5B annual medical spend, 145,000 patients nationwide, and over 6,500 provider partners, with expansions into AI tools and multi-specialty services like heart failure.
Mar 2021Series BCapitalG (lead); Redpoint; Town Hall Ventures; New Enterprise Associates; Echo Health Ventures; Ascension Ventures$140M-Strive Health is a Denver-based company providing value-based kidney care, combining technology, data analytics, and in-person care to slow kidney disease progression, reduce inpatient utilization, increase home dialysis adoption, and improve patient outcomes. The company secured a $140 million Series B funding round on March 16, 2021, led by Alphabet's CapitalG, with participation from new investor Redpoint and existing investors New Enterprise Associates (NEA), Town Hall Ventures, Ascension Ventures, and Echo Health Ventures. This brought total funding to $223.5 million, following an $80 million Series A in 2018 led by NEA. The financing aims to support scaling to meet growing demand for Strive's whole-patient kidney care solution, including technology and product development, hiring more caregivers, expanding into new markets, and partnering with additional payors, health systems, at-risk provider groups, and nephrologists. Strive has contracts with major payors and providers like Humana, Blue Cross and Blue Shield of North Carolina, SSM Health, and Conviva Care Centers, plus partnerships with hundreds of nephrology providers under new Medicare models. Its AI-powered models predict disease progression with over 95% accuracy, and programs have shown up to 29% reduction in total healthcare spend. CapitalG partner Sumi Das highlighted Strive's best-in-class technology, care model, and team in the emerging kidney care segment, addressing underserved chronic and end-stage kidney disease patients amid shifts to value-based care. CEO Chris Riopelle emphasized leveraging Google and Alphabet expertise for growth and technology enhancement. The round positions Strive as a leader tackling the $410 billion unmanaged kidney disease spend, with aggressive expansion plans. Later rounds include a $550 million Series D in September 2025 led by NEA, valuing the company at $1.8 billion and managing nearly $5 billion in annual medical spend.
Apr 2019Series ANew Enterprise Associates (lead); Town Hall Ventures; Echo Health Ventures; Oxeon Partners; Ascension Ventures$80M--

Who has invested in Strive Health?

9 investors have backed Strive Health across its funding rounds, including New Enterprise Associates, Echo Health Ventures, Town Hall Ventures, Redpoint, CapitalG and Ascension Ventures.

Lead investors include New Enterprise Associates and CapitalG.


Strive Health Investors

Investors in Strive Health by funding rounds participated
InvestorHQRoundsRoleFirst check
Town Hall VenturesUnited StatesNew York City, NY4ParticipantApr 2019
New Enterprise AssociatesUnited StatesSan Francisco, CA4LeadApr 2019
Echo Health VenturesUnited StatesSeattle, WA4ParticipantApr 2019
RedpointUnited StatesSan Francisco, CA3ParticipantMar 2021
CapitalGUnited StatesSan Francisco, CA3LeadMar 2021
Ascension VenturesUnited StatesClarkton, NC3ParticipantApr 2019
CVS Health VenturesUnited StatesProvidence, RI2ParticipantMay 2023

This data is available for Pro users. Sign up to see all 9 Strive Health investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Strive Health Competitors

Strive Health competitors include listed companies like Omnicell and Indegene, and private ones like MediTrust Health, Somatus, UpStream Care and Aledade.

Public and private companies comparable to Strive Health
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
MediTrust HealthChinaShanghaiPrivate$154M-$1.4B9.3x
SomatusUnited StatesWashington, DCPrivate--$2.5B-
UpStream CareUnited StatesGreensboro, NCPrivate--$1B-
AledadeUnited StatesWashington, DCPrivate$475M-$3.5B7.4x
OmnicellUnited StatesUnited StatesPublicly listed$1.2B$92M$1.5B1.1x
IndegeneIndiaIndiaPublicly listed$366M$68M$1.5B3.3x

Strive Health Public Comps

Strive Health is still privately-owned, but its public comps include Alignment Healthcare, Qingdao Baheal Medical, Omnicell, Indegene, EverCommerce, Schrödinger, U.S. Physical Therapy, Clover Health, Tieto and PHC Holdings.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Alignment Healthcare$3.9B$45M0.4x0.3x31.6x10.0x
Qingdao Baheal Medical$1.1B$139M1.9x1.9x15.1x16.8x
Omnicell$1.2B$92M1.2x1.1x15.0x8.1x
Indegene$366M$68M3.7x3.3x19.9x18.2x
EverCommerce$589M$128M3.0x2.9x13.7x9.5x
Schrödinger$256M($96M)7.6x7.9x(20.3x)(14.0x)
U.S. Physical Therapy$781M$110M2.5x2.3x17.5x18.9x
Clover Health$1.9B($84M)1.1x0.8x(25.8x)34.1x

This data is available for Pro users. Sign up to see all Strive Health competitors and their valuation data.

Start Free Trial

Common questions about Strive Health

When was Strive Health founded?Strive Health was founded in 2018.
Where is Strive Health headquartered?Strive Health is headquartered in Denver, CO, United States.
Is Strive Health publicly listed?No, Strive Health is a private, VC-backed company.
What is Strive Health's valuation?Strive Health was last valued at $1.8B in its Series D in September 2025.
How much funding has Strive Health raised?Strive Health has raised $686M across 4 funding rounds.
What was Strive Health's last funding round?Strive Health's last funding round was a $300M Series D in September 2025, led by New Enterprise Associates.
Who are Strive Health's investors?Strive Health's investors include Town Hall Ventures, New Enterprise Associates, Echo Health Ventures, Redpoint, CapitalG, Ascension Ventures, CVS Health Ventures, BlackRock and Oxeon Partners.
Which companies are comparable to Strive Health?Companies comparable to Strive Health include MediTrust Health, Somatus, UpStream Care, Aledade, Omnicell and Indegene.

See companies similar to Strive Health

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial